Valuation: Treace Medical Concepts, Inc.

Market Cap 272M 244M 223M 203M 383M 25.55B 395M 2.69B 1.07B 13.64B 1.02B 998M 43.04B P/E 2026 *
-4.91x
P/E 2027 * -5.4x
Enterprise Value 318M 285M 260M 238M 448M 29.85B 462M 3.14B 1.25B 15.93B 1.19B 1.17B 50.28B EV / Sales 2026 *
1.53x
EV / Sales 2027 * 1.62x
Free-Float
74.47%
Yield 2026 *
-
Yield 2027 * -
1 day-5.74%
1 week-9.26%
Current month-9.26%
1 month+0.50%
3 months-8.22%
6 months+108.29%
Current year+64.08%
1 week 3.42
Extreme 3.42
4.82
1 month 3.42
Extreme 3.42
5.25
Current year 1.17
Extreme 1.17
5.25
1 year 1.17
Extreme 1.17
5.25
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
27.97
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Chief Tech/Sci/R&D Officer - 01/03/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/9/26 Tax

Compliance Officer

-25,457 0.0391%
24/8/26 Buy

Chief Executive Officer

11,000 0.0170%
9/8/26 Tax

Chief Financial Officer

-37,102 0.0572%
Change 5-day change 1-year change 3-year change Capi.($)
-5.86%-9.26%-35.47%-62.92% 272M
-2.61%+4.03%-11.58%+16.29% 197B
-2.89%+11.71%-7.85%+17.77% 128B
-2.44%+6.04%+13.67%+39.43% 128B
+0.96%+5.15%-38.02%+12.24% 99B
-0.93%+1.44%-6.84%+70.45% 64.82B
-0.96%+7.14%+19.51%-18.18% 58.17B
+0.89%+22.67%-5.27%+59.84% 52.84B
-6.98%-14.94%-9.70%+46.32% 50.69B
-2.36%+3.72%+3.27%-8.07% 37.23B
Average -2.25%+4.60%-7.83%+17.32% 81.57B
Weighted average by Cap. -1.93%+7.56%-6.44%+25.07%

Financials

2026 *2027 *
Net sales 207M 186M 170M 155M 292M 19.5B 302M 2.05B 817M 10.41B 779M 762M 32.85B 222M 199M 182M 166M 313M 20.84B 322M 2.19B 874M 11.12B 832M 814M 35.11B
Net income -55.26M -49.57M -45.3M -41.35M -77.91M -5.19B -80.37M -546M -218M -2.77B -207M -203M -8.75B -51.01M -45.75M -41.81M -38.17M -71.91M -4.8B -74.18M -504M -201M -2.56B -191M -187M -8.08B
Net Debt 45.67M 40.96M 37.43M 34.17M 64.38M 4.29B 66.41M 451M 180M 2.29B 171M 168M 7.23B 86.44M 77.53M 70.85M 64.68M 122M 8.13B 126M 854M 341M 4.34B 324M 317M 13.69B
Projected Income Statement - Annual - Treace Medical Concepts, Inc.
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
07/11/26 USD 4.040 -3.35% 401,832
05/11/26 USD 4.180 -7.11% 323,314
04/11/26 USD 4.500 +5.14% 270,172
03/11/26 USD 4.280 +0.23% 211,636
02/11/26 USD 4.270 -3.61% 168,692
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Treace Medical Concepts, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.180USD
Average target price
5.500USD
Spread / Average Target
+31.58%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Treace Medical Concepts, Inc.
  1. Stock Market
  2. Stocks
  3. TMCI Stock